+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
GI Stool Testing Market - Global Forecast 2026-2032- Product Image
GI Stool Testing Market - Global Forecast 2026-2032- Product Image
New

GI Stool Testing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 186 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5977951
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The GI stool testing market is rapidly evolving as senior healthcare leaders navigate a dynamic environment shaped by new diagnostics, shifting regulatory landscapes, and operational pressures. This report delivers a clear, actionable overview for decision-makers seeking to position their organizations at the forefront of innovation and clinical value delivery in gastrointestinal diagnostics.

Market Snapshot: GI Stool Testing Market Size and Growth

The GI stool testing market grew from USD 739.52 million in 2025 to USD 785.58 million in 2026 and is projected to continue expanding at a CAGR of 6.95%, reaching USD 1.18 billion by 2032. Growth is fueled by advancements in molecular diagnostics, automation, and digital integration, driving adoption across infection detection, cancer screening, and microbiome research.

Scope & Segmentation of the Gastrointestinal Stool Testing Market

  • Test Types: Includes culture-based assays for phenotypic antimicrobial susceptibility, immunoassay platforms for antigen detection, and PCR-based methods for high-sensitivity pathogen identification.
  • Clinical Applications: Supports infectious disease management, cancer screening using molecular markers, and precision medicine through comprehensive microbiome analysis.
  • Technologies: Encompasses chemiluminescent and enzyme-linked immunoassays, lateral flow tests, microarrays for profiling, digital PCR, isothermal amplification, real-time PCR, and next-generation sequencing platforms.
  • End-User Segments: Targets diagnostic laboratories, hospitals, reference laboratories, and research institutes, each differentiated by validation, throughput, and procurement priorities.
  • Distribution Pathways: Product access routes include direct sales, online channels, and third-party distributors, influencing time-to-clinic and market penetration.
  • Regional Coverage: Analysis spans the Americas, Europe, Middle East & Africa, and Asia-Pacific, addressing variable regulatory landscapes, clinical adoption drivers, and supply chain resiliency.

Key Takeaways for Senior Decision-Makers

  • Technological convergence between advanced molecular assays and point-of-care immunoassays is redefining diagnostic pathways and supporting tailored clinical workflows.
  • Emerging regulatory and payer environments drive laboratories to rethink value-based strategies and adapt clinical pathways, optimizing both reimbursement and quality management.
  • Operational strategies increasingly prioritize workflow efficiency, reagent standardization, and lab automation to integrate newer multiplexed diagnostics into existing systems.
  • Strategic partnerships among instrumentation providers, reagent suppliers, and reference labs foster innovation while underpinning robust clinical evidence and streamlined adoption cycles.
  • Regional adaptation is critical, as market entry success and product uptake rely on harmonizing technical validation and local market access strategies with shifting clinical and regulatory requirements.

Tariff Impact on Sourcing and Cost Structures

Cumulative tariff measures introduced in 2025 have added complexity for vendors and procurement teams active in the gastrointestinal stool testing sector. These tariffs, affecting imported reagents, disposables, and equipment, have prompted manufacturers and laboratories to rethink supplier portfolios, invest in local sourcing, and pursue vertical integration to shield operations from elevated import duties and supply chain disruptions. Resultant shifts encourage renegotiation of service contracts, adoption of reagent rental models, and reevaluation of pricing strategies to safeguard competitiveness and maintain access to vital testing modalities.

Primary Keyword Focus: GI Stool Testing Market

The GI stool testing market is witnessing increasing convergence of cutting-edge molecular technologies and established immunoassay platforms, driving accessibility and outcome-focused product development in diverse care settings.

Methodology & Data Sources

This analysis combines primary interviews with laboratory directors, clinical microbiologists, procurement leaders, and diagnostics executives alongside secondary review of regulatory documents, peer-reviewed literature, and technical product filings. Triangulation of qualitative and quantitative findings ensured robust validation of diagnostic trends, regional patterns, and emerging strategic imperatives.

Why This Report Matters

  • Clarifies how evolving technologies and regulatory dynamics impact commercial and clinical strategies, enabling effective allocation of investment and resources.
  • Equips leaders with a segmentation framework to link clinical needs, technology choices, and distribution models for market-aligned decision-making.
  • Offers a roadmap for building operational resilience and strategic agility in response to external pressures like tariffs, supply chain disruptions, and shifting payer policies.

Conclusion

Senior executives equipped with this report will be able to navigate regulatory and operational challenges, align product portfolios with clinical value, and leverage strategic partnerships for optimal positioning in the evolving GI stool testing market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. GI Stool Testing Market, by Test Type
8.1. Culture
8.2. Immunoassay
8.3. Polymerase Chain Reaction
9. GI Stool Testing Market, by Technology
9.1. Immunoassays
9.1.1. Chemiluminescent Immunoassay
9.1.2. Elisa
9.1.3. Lateral Flow
9.2. Microarrays
9.3. Molecular Diagnostics
9.3.1. Digital PCR
9.3.2. Isothermal Amplification
9.3.3. Real Time PCR
9.4. Next Generation Sequencing
10. GI Stool Testing Market, by Application
10.1. Cancer Screening
10.2. Infectious Disease
10.3. Microbiome Analysis
11. GI Stool Testing Market, by End User
11.1. Diagnostic Laboratories
11.2. Hospitals
11.3. Reference Laboratories
11.4. Research Institutes
12. GI Stool Testing Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. GI Stool Testing Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. GI Stool Testing Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States GI Stool Testing Market
16. China GI Stool Testing Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbott Laboratories
17.6. Becton Dickinson & Company
17.7. Bio-Rad Laboratories
17.8. bioMérieux Inc.
17.9. Cardinal Health Inc.
17.10. Cenogenics Corporation
17.11. CTK Biotech Inc.
17.12. Danaher Corporation
17.13. Diagnostic Solutions Laboratory
17.14. DiaSorin S.p.A.
17.15. Doctors Data
17.16. Epitope Diagnostics Inc.
17.17. Eurofins
17.18. Genova Diagnostics
17.19. Hologic Inc.
17.20. Meridian Bioscience Inc.
17.21. Metropolis Healthcare Ltd
17.22. Qiagen
17.23. Quest Diagnostics Incorporated
17.24. QuidelOrtho Corporation
17.25. Randox Laboratories
17.26. Roche Diagnostics
17.27. ScheBo Biotech AG
17.28. Siemens Healthineers
17.29. Thermo Fisher Scientific, Inc.
List of Figures
FIGURE 1. GLOBAL GI STOOL TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL GI STOOL TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL GI STOOL TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL GI STOOL TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL GI STOOL TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL GI STOOL TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES GI STOOL TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA GI STOOL TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL GI STOOL TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL GI STOOL TESTING MARKET SIZE, BY CULTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL GI STOOL TESTING MARKET SIZE, BY CULTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL GI STOOL TESTING MARKET SIZE, BY CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL GI STOOL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL GI STOOL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL GI STOOL TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL GI STOOL TESTING MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL GI STOOL TESTING MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL GI STOOL TESTING MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL GI STOOL TESTING MARKET SIZE, BY ELISA, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL GI STOOL TESTING MARKET SIZE, BY ELISA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL GI STOOL TESTING MARKET SIZE, BY ELISA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL GI STOOL TESTING MARKET SIZE, BY LATERAL FLOW, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL GI STOOL TESTING MARKET SIZE, BY LATERAL FLOW, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL GI STOOL TESTING MARKET SIZE, BY LATERAL FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL GI STOOL TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL GI STOOL TESTING MARKET SIZE, BY MICROARRAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL GI STOOL TESTING MARKET SIZE, BY MICROARRAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL GI STOOL TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL GI STOOL TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL GI STOOL TESTING MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL GI STOOL TESTING MARKET SIZE, BY REAL TIME PCR, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL GI STOOL TESTING MARKET SIZE, BY REAL TIME PCR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL GI STOOL TESTING MARKET SIZE, BY REAL TIME PCR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL GI STOOL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL GI STOOL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL GI STOOL TESTING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL GI STOOL TESTING MARKET SIZE, BY CANCER SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL GI STOOL TESTING MARKET SIZE, BY CANCER SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL GI STOOL TESTING MARKET SIZE, BY CANCER SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL GI STOOL TESTING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL GI STOOL TESTING MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL GI STOOL TESTING MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL GI STOOL TESTING MARKET SIZE, BY MICROBIOME ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL GI STOOL TESTING MARKET SIZE, BY MICROBIOME ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL GI STOOL TESTING MARKET SIZE, BY MICROBIOME ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL GI STOOL TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL GI STOOL TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL GI STOOL TESTING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL GI STOOL TESTING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL GI STOOL TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL GI STOOL TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL GI STOOL TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL GI STOOL TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL GI STOOL TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL GI STOOL TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL GI STOOL TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. AMERICAS GI STOOL TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 70. AMERICAS GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 71. AMERICAS GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 72. AMERICAS GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 73. AMERICAS GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 76. NORTH AMERICA GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. NORTH AMERICA GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 78. NORTH AMERICA GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 83. LATIN AMERICA GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. LATIN AMERICA GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 85. LATIN AMERICA GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 87. LATIN AMERICA GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 88. LATIN AMERICA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 97. EUROPE GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. EUROPE GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 99. EUROPE GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 100. EUROPE GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 101. EUROPE GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 102. EUROPE GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 103. EUROPE GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 104. MIDDLE EAST GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. MIDDLE EAST GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 106. MIDDLE EAST GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 107. MIDDLE EAST GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 108. MIDDLE EAST GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 109. MIDDLE EAST GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 110. MIDDLE EAST GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 111. AFRICA GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. AFRICA GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 113. AFRICA GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 114. AFRICA GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 115. AFRICA GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 116. AFRICA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 117. AFRICA GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL GI STOOL TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. ASEAN GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. ASEAN GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 128. ASEAN GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 129. ASEAN GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 130. ASEAN GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 131. ASEAN GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 132. ASEAN GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 133. GCC GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GCC GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 135. GCC GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 136. GCC GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 137. GCC GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 138. GCC GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 139. GCC GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 140. EUROPEAN UNION GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. EUROPEAN UNION GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 142. EUROPEAN UNION GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 143. EUROPEAN UNION GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 144. EUROPEAN UNION GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 145. EUROPEAN UNION GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 147. BRICS GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. BRICS GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 149. BRICS GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 150. BRICS GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 151. BRICS GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 152. BRICS GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 153. BRICS GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 154. G7 GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. G7 GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 156. G7 GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 157. G7 GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 158. G7 GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 159. G7 GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. G7 GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. NATO GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. NATO GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 163. NATO GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 164. NATO GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 165. NATO GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 166. NATO GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 167. NATO GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL GI STOOL TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. UNITED STATES GI STOOL TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 170. UNITED STATES GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 171. UNITED STATES GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 172. UNITED STATES GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 173. UNITED STATES GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 174. UNITED STATES GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 175. UNITED STATES GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 176. CHINA GI STOOL TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 177. CHINA GI STOOL TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 178. CHINA GI STOOL TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 179. CHINA GI STOOL TESTING MARKET SIZE, BY IMMUNOASSAYS, 2018-2032 (USD MILLION)
TABLE 180. CHINA GI STOOL TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 181. CHINA GI STOOL TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 182. CHINA GI STOOL TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this GI Stool Testing market report include:
  • Abbott Laboratories
  • Becton Dickinson & Company
  • Bio-Rad Laboratories
  • bioMérieux Inc.
  • Cardinal Health Inc.
  • Cenogenics Corporation
  • CTK Biotech Inc.
  • Danaher Corporation
  • Diagnostic Solutions Laboratory
  • DiaSorin S.p.A.
  • Doctors Data
  • Epitope Diagnostics Inc.
  • Eurofins
  • Genova Diagnostics
  • Hologic Inc.
  • Meridian Bioscience Inc.
  • Metropolis Healthcare Ltd
  • Qiagen
  • Quest Diagnostics Incorporated
  • QuidelOrtho Corporation
  • Randox Laboratories
  • Roche Diagnostics
  • ScheBo Biotech AG
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.

Table Information

Report AttributeDetails
No. of Pages186
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 785.58 Million
Forecasted Market Value ( USD ) by 2032 $ 1180 Million
Compound Annual Growth Rate6.9%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

GI Stool Testing - Global Strategic Business Report - Product Image

GI Stool Testing - Global Strategic Business Report

  • Report
  • 576 Pages
  • Global
From
Rapid Microbiology Testing Market - Global Forecast 2026-2032 - Product Image

Rapid Microbiology Testing Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Microbial Identification & Typing Service Market - Global Forecast 2025-2030 - Product Image

Microbial Identification & Typing Service Market - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Chemiluminescence Immunoassay Analyzer Market Report 2025 - Product Image

Chemiluminescence Immunoassay Analyzer Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Infectious Disease in Vitro Diagnostics Global Market Report 2025 - Product Image

Infectious Disease in Vitro Diagnostics Global Market Report 2025

  • Report
  • 250 Pages
  • Global
From

About the GI Stool Test Market

The GI Stool Test market within the context of In Vitro Diagnostics is a segment of the medical diagnostics industry that focuses on the detection of gastrointestinal diseases and disorders. It is a rapidly growing market, driven by the increasing prevalence of gastrointestinal diseases and the need for early diagnosis and treatment. GI Stool Tests are used to detect a variety of gastrointestinal conditions, including bacterial infections, parasites, and inflammatory bowel disease. These tests are typically performed in a laboratory setting and can provide valuable information to healthcare providers. The GI Stool Test market is highly competitive, with a number of companies offering a range of products and services. Some of the major players in the market include Quest Diagnostics, LabCorp, Bio-Rad Laboratories, and Genova Diagnostics. Other companies in the market include Eurofins Scientific, Mayo Medical Laboratories, and ARUP Laboratories. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.